Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Document And Entity Information

Document And Entity Information
12 Months Ended
Dec. 31, 2020
Document Information Line Items  
Entity Registrant Name Can-Fite BioPharma Ltd.
Document Type 20-F
Current Fiscal Year End Date --12-31
Entity Common Stock, Shares Outstanding 463,769,463
Amendment Flag false
Entity Central Index Key 0001536196
Entity Current Reporting Status Yes
Entity Voluntary Filers No
Entity Filer Category Non-accelerated Filer
Entity Well-known Seasoned Issuer No
Document Period End Date Dec. 31, 2020
Document Fiscal Year Focus 2020
Document Fiscal Period Focus FY
Entity Emerging Growth Company false
Entity Shell Company false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Entity File Number 001-36203
Entity Incorporation, State or Country Code L3
Entity Interactive Data Current Yes